199 related articles for article (PubMed ID: 37761922)
21. Clinical and molecular features of four Brazilian families with multiple endocrine neoplasia type 1.
Miranda ISM; Valadares LP; Barra GB; Mesquita PG; de Santana LB; de Castro LF; Rita THS; Naves LA
Front Endocrinol (Lausanne); 2023; 14():1117873. PubMed ID: 36967793
[TBL] [Abstract][Full Text] [Related]
22. Understanding the clinical course of genotype-negative MEN1 patients can inform management strategies.
Pieterman CRC; Hyde SM; Wu SY; Landry JP; Chiang YJ; Christakis I; Grubbs EG; Fisher SB; Graham PH; Waguespack SG; Perrier ND
Surgery; 2021 Jan; 169(1):175-184. PubMed ID: 32703679
[TBL] [Abstract][Full Text] [Related]
23. Unraveling the intrafamilial correlations and heritability of tumor types in MEN1: a Groupe d'étude des Tumeurs Endocrines study.
Thevenon J; Bourredjem A; Faivre L; Cardot-Bauters C; Calender A; Le Bras M; Giraud S; Niccoli P; Odou MF; Borson-Chazot F; Barlier A; Lombard-Bohas C; Clauser E; Tabarin A; Pasmant E; Chabre O; Castermans E; Ruszniewski P; Bertherat J; Delemer B; Christin-Maitre S; Beckers A; Guilhem I; Rohmer V; Goichot B; Caron P; Baudin E; Chanson P; Groussin L; Du Boullay H; Weryha G; Lecomte P; Schillo F; Bihan H; Archambeaud F; Kerlan V; Bourcigaux N; Kuhn JM; Vergès B; Rodier M; Renard M; Sadoul JL; Binquet C; Goudet P
Eur J Endocrinol; 2015 Dec; 173(6):819-26. PubMed ID: 26392472
[TBL] [Abstract][Full Text] [Related]
24. ARMC5 Alterations in Patients With Sporadic Neuroendocrine Tumors and Multiple Endocrine Neoplasia Type 1 (MEN1).
Damjanovic SS; Antic JA; Elezovic-Kovacevic VI; Dundjerovic DM; Milicevic IT; Beleslin-Cokic BB; Ilic BB; Rodic GS; Berthon A; Maria AG; Faucz FR; Stratakis CA
J Clin Endocrinol Metab; 2020 Dec; 105(12):e4531-42. PubMed ID: 32901291
[TBL] [Abstract][Full Text] [Related]
25. Thymic neuroendocrine tumour in multiple endocrine neoplasia type 1: female patients are not rare exceptions.
Sakurai A; Imai T; Kikumori T; Horiuchi K; Okamoto T; Uchino S; Kosugi S; Suzuki S; Suyama K; Yamazaki M; Sato A;
Clin Endocrinol (Oxf); 2013 Feb; 78(2):248-54. PubMed ID: 22690831
[TBL] [Abstract][Full Text] [Related]
26. [Clinical genetics of neuroendocrine tumors].
Karges W; Adler G
Med Klin (Munich); 2003 Dec; 98(12):712-6. PubMed ID: 14685672
[TBL] [Abstract][Full Text] [Related]
27. New therapies for patients with multiple endocrine neoplasia type 1.
Geslot A; Vialon M; Caron P; Grunenwald S; Vezzosi D
Ann Endocrinol (Paris); 2021 Apr; 82(2):112-120. PubMed ID: 33839123
[TBL] [Abstract][Full Text] [Related]
28. Clinical Features of Multiple Endocrine Neoplasia Type 4: Novel Pathogenic Variant and Review of Published Cases.
Frederiksen A; Rossing M; Hermann P; Ejersted C; Thakker RV; Frost M
J Clin Endocrinol Metab; 2019 Sep; 104(9):3637-3646. PubMed ID: 30990521
[TBL] [Abstract][Full Text] [Related]
29. Beyond MEN1, when to think about MEN4? Retrospective study on 5600 patients in the French population & literature review.
Chevalier B; Coppin L; Romanet P; Cuny T; Maiza JC; Abeillon J; Forestier J; Walter T; Gilly O; Le Bras M; Smati S; Nunes ML; Geslot A; Grunenwald S; Mouly C; Arnault G; Wagner K; Koumakis E; Cortet-Rudelli C; Merlen É; Jannin A; Espiard S; Morange I; Baudin É; Cavaille M; Tauveron I; Teissier MP; Borson-Chazot F; Mirebeau-Prunier D; Savagner F; Pasmant É; Giraud S; Vantyghem MC; Goudet P; Barlier A; Cardot-Bauters C; Odou MF
J Clin Endocrinol Metab; 2024 Jan; ():. PubMed ID: 38288531
[TBL] [Abstract][Full Text] [Related]
30. Multiple endocrine neoplasia type 1 syndrome: single centre experience from western India.
Goroshi M; Bandgar T; Lila AR; Jadhav SS; Khare S; Shrikhande SV; Uchino S; Dalvi AN; Shah NS
Fam Cancer; 2016 Oct; 15(4):617-24. PubMed ID: 26905068
[TBL] [Abstract][Full Text] [Related]
31. Clinical and prognostic implications of the genetic diagnosis of hereditary NET syndromes in asymptomatic patients.
Ramundo V; Milone F; Severino R; Savastano S; Di Somma C; Vuolo L; De Luca L; Lombardi G; Colao A; Faggiano A
Horm Metab Res; 2011 Oct; 43(11):794-800. PubMed ID: 22009375
[TBL] [Abstract][Full Text] [Related]
32. No Association of Blood Type O With Neuroendocrine Tumors in Multiple Endocrine Neoplasia Type 1.
Nell S; van Leeuwaarde RS; Pieterman CR; de Laat JM; Hermus AR; Dekkers OM; de Herder WW; van der Horst-Schrivers AN; Drent ML; Bisschop PH; Havekes B; Borel Rinkes IH; Vriens MR; Valk GD
J Clin Endocrinol Metab; 2015 Oct; 100(10):3850-5. PubMed ID: 26247473
[TBL] [Abstract][Full Text] [Related]
33. Multiple endocrine neoplasia type 1 with Zollinger-Ellison syndrome: clinicopathological analysis of a Japanese family with focus on menin immunohistochemistry.
Kimura N; Hirata Y; Iwashiro N; Kijima H; Takayasu S; Yamagata S; Sakihara S; Uchino S; Ohara M
Front Endocrinol (Lausanne); 2023; 14():1221514. PubMed ID: 37867522
[TBL] [Abstract][Full Text] [Related]
34. A germline c.1546dupC MEN1 mutation in an MEN1 family: A case report.
Cho YY; Chung YJ
Medicine (Baltimore); 2021 Jun; 100(25):e26382. PubMed ID: 34160414
[TBL] [Abstract][Full Text] [Related]
35. MEN1 disease occurring before 21 years old: a 160-patient cohort study from the Groupe d'étude des Tumeurs Endocrines.
Goudet P; Dalac A; Le Bras M; Cardot-Bauters C; Niccoli P; Lévy-Bohbot N; du Boullay H; Bertagna X; Ruszniewski P; Borson-Chazot F; Vergès B; Sadoul JL; Ménégaux F; Tabarin A; Kühn JM; d'Anella P; Chabre O; Christin-Maitre S; Cadiot G; Binquet C; Delemer B
J Clin Endocrinol Metab; 2015 Apr; 100(4):1568-77. PubMed ID: 25594862
[TBL] [Abstract][Full Text] [Related]
36. Penetrance of functioning and nonfunctioning pancreatic neuroendocrine tumors in multiple endocrine neoplasia type 1 in the second decade of life.
Gonçalves TD; Toledo RA; Sekiya T; Matuguma SE; Maluf Filho F; Rocha MS; Siqueira SA; Glezer A; Bronstein MD; Pereira MA; Jureidini R; Bacchella T; Machado MC; Toledo SP; Lourenço DM
J Clin Endocrinol Metab; 2014 Jan; 99(1):E89-96. PubMed ID: 24178797
[TBL] [Abstract][Full Text] [Related]
37. Pancreatic neuroendocrine tumors in MEN1 disease: a mono-centric longitudinal and prognostic study.
Chiloiro S; Lanza F; Bianchi A; Schinzari G; Brizi MG; Giampietro A; Rufini V; Inzani F; Giordano A; Rindi G; Pontecorvi A; De Marinis L
Endocrine; 2018 May; 60(2):362-367. PubMed ID: 28567607
[TBL] [Abstract][Full Text] [Related]
38. Clinical features and prognosis of thymic neuroendocrine tumours associated with multiple endocrine neoplasia type 1: A single-centre study, systematic review and meta-analysis.
Ye L; Wang W; Ospina NS; Jiang L; Christakis I; Lu J; Zhou Y; Zhu W; Cao Y; Wang S; Perrier ND; Young WF; Ning G; Wang W
Clin Endocrinol (Oxf); 2017 Dec; 87(6):706-716. PubMed ID: 28940393
[TBL] [Abstract][Full Text] [Related]
39. Natural History of MEN1 GEP-NET: Single-Center Experience After a Long Follow-Up.
Giudici F; Cavalli T; Giusti F; Gronchi G; Batignani G; Tonelli F; Brandi ML
World J Surg; 2017 Sep; 41(9):2312-2323. PubMed ID: 28429092
[TBL] [Abstract][Full Text] [Related]
40. Frequency of multiple endocrine neoplasia type 1 in a group of patients with pituitary adenoma: genetic study and familial screening.
Nunes VS; Souza GL; Perone D; Conde SJ; Nogueira CR
Pituitary; 2014 Feb; 17(1):30-7. PubMed ID: 23334809
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
